<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This meeting was convened by Richard T </plain></SENT>
<SENT sid="1" pm="."><plain>Silver and co-chaired by Jerry L </plain></SENT>
<SENT sid="2" pm="."><plain>Spivak </plain></SENT>
<SENT sid="3" pm="."><plain>It was held from 27 to 29 October 2005 in Washington, DC </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty-one invited speakers from seven different countries participated in the conference, which was attended by more than 300 individuals from 23 countries </plain></SENT>
<SENT sid="5" pm="."><plain>As in previous years, a clinical symposium for patients, held the day before the symposium, was sponsored by the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Research and Treatment Fund, Inc., New York, NY 10021 </plain></SENT>
<SENT sid="6" pm="."><plain>This meeting report provides a summary of the five sessions prepared and highlighted by one of the session chairs </plain></SENT>
<SENT sid="7" pm="."><plain>In addition to the formal presentations on the biology, clinical aspects and management of these diverse marrow stem cell disorders, there was considerable interest generated because of the availability of several new agents that have been recently approved </plain></SENT>
<SENT sid="8" pm="."><plain>A special luncheon satellite symposium was devoted to the dramatic changes in the therapeutic options for the <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, sponsored by MGI Pharma, Inc </plain></SENT>
<SENT sid="9" pm="."><plain>The keynote address was presented by Dr. George Q </plain></SENT>
<SENT sid="10" pm="."><plain>Daley from Harvard Medical School and the Children's Hospital Medical Center </plain></SENT>
<SENT sid="11" pm="."><plain>He reviewed the molecular steps in the formation of the Philadelphia chromosome and some of the newly described mutations leading to resistance to chemotherapy (see Section 4) </plain></SENT>
</text></document>